Aligos Therapeutics, Inc. - ALGS

Sector: Healthcare · Industry: Biological Products, (No Diagnostic Substances)
Website: No information yet · Social: No information yet

Company profile

Powered by TradingView

Quarter snapshot

Latest / Compare
Q3 2026 · Q2 2026
Value (USD)
Total reported value ($000)
$13.21M
QoQ value delta ($000)
$0 (0.0%)
Implied price effect (QoQ)
0.0%
Shares
Total shares
2,292,538
QoQ shares delta
0 (0.0%)
Total shares held by funds (by quarter)
Shares (left)

Fund holders include prior positions carried forward until a new 13F confirms a change. Reported holders have reported a position in this security for that quarter; this is not the total number of 13F filers.

Market chart (ALGS)

Powered by TradingView
Interactive chart by TradingView.

Top holders (Q3 2026)

Top 25 only Full list
Partial Q3 2026 data: 1 holders have filed so far. Prior holders are carried forward until their next 13F confirms a change.
Manager Value ($000) Shares % of 13F
Deep Track Capital, LP 2,562 444,110 0.04%
Alyeska Investment Group, L.P. 2,377 412,000 0.01%
Sio Capital Management, LLC 1,888 327,237 0.31%
MARSHALL WACE, LLP 1,422 246,579 0.0%
Woodline Partners LP 1,023 177,362 0.0%
VANGUARD CAPITAL MANAGEMENT LLC 1,012 175,543 0.0%
BAKER BROS. ADVISORS LP 479 83,055 0.0%
HHLR ADVISORS, LTD. 439 76,247 0.05%
D. E. Shaw & Co., Inc. 383 66,463 0.0%
UBS Group AG 346 59,986 0.0%
GEODE CAPITAL MANAGEMENT, LLC 272 47,173 0.0%
JANE STREET GROUP, LLC 186 32,402 0.0%
BlackRock, Inc. 174 30,292 0.0%
VANGUARD FIDUCIARY TRUST CO 165 28,612 0.0%
DIMENSIONAL FUND ADVISORS LP 121 21,044 0.0%
Verition Fund Management LLC 108 18,887 0.0%
Trexquant Investment LP 71 12,339 0.0%
RENAISSANCE TECHNOLOGIES LLC 62 10,800 0.0%
Rockefeller Capital Management L.P. 57 10,000 0.0%
Federation des caisses Desjardins du Quebec 26 4,650 0.0%
Golden State Wealth Management, LLC 15 2,674 0.0%
ROYAL BANK OF CANADA 12 2,125 0.0%
CITIGROUP INC 10 1,808 0.0%
Tower Research Capital LLC (TRC) 2 359 0.0%
JPMORGAN CHASE & CO 1 344 0.0%